The European Respiratory Society evaluates its 2013–2018 strategic plan implementation

Migliori, Giovanni Battista; Bel, Elisabeth H.; Joos, Guy; Elliott, Mark; Rohde, Gernot; Holgate, Stephen T.; Gratziou, Christina; Smyth, Dan; Gaga, Mina; Cordeiro, Carlos Robeiro; Burghuber, Otto Chris; Martin-Burrieza, Fernando; Bill, Werner; Sax, Betty; Vestbo, Jørgen

doi:10.1183/13993003.02110-2015

Cited by 3 publications

(3 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Horizon 2020 applications) [14]. In conclusion, as illustrated in this short synopsis of expanding ERS scientific activities, fostering and coordinating international research collaborations in asthma and other respiratory diseases are core activities within the ERS [15].…”

Section: Asthma Research Collaborations: the Wider Opportunities Withmentioning

confidence: 94%

The era of research collaborations: new models for working together

et al. 2017

Self Cite

View full text Add to dashboard Cite

Section: Asthma Research Collaborations: the Wider Opportunities Withmentioning

confidence: 94%

The era of research collaborations: new models for working together

et al. 2017

Self Cite

View full text Add to dashboard Cite

“…Пять заболеваний (включая бронхиальную астму) являются самыми распространенными причинами тяжелых состояний и летальных исходов. Повышая уровень науки и образования в сфере болезней органов дыхания, можно улучшить лечение хронических респираторных заболеваний не только в Европе, но и во всем мире [24].…”

Section: европейское респираторное обществоunclassified

Prioritizing Research Challenges and Funding for Allergy and Asthma and the Need for Translational Research — The European Strategic Forum on Allergic Diseases

et al. 2020

View full text Add to dashboard Cite

The European Academy of Allergy and Clinical Immunology (EAACI) organized the first European Strategic Forum on Allergic Diseases and Asthma. The main aim was to bring together all relevant stakeholders and decision‐makers in the field of allergy, asthma and clinical Immunology around an open debate on contemporary challenges and potential solutions for the next decade. The Strategic Forum was an upscaling of the EAACI White Paper aiming to integrate the Academy’s output with the perspective offered by EAACI’s partners. This collaboration is fundamental for adapting and integrating allergy and asthma care into the context of real‐world problems. The Strategic Forum on Allergic Diseases brought together all partners who have the drive and the influence to make positive change: national and international societies, patients’ organizations, regulatory bodies and industry representatives. An open debate with a special focus on drug development and biomedical engineering, big data and information technology and allergic diseases and asthma in the context of environmental health concluded that connecting science with the transformation of care and a joint agreement between all partners on priorities and needs are essential to ensure a better management of allergic diseases and asthma in the advent of precision medicine together with global access to innovative and affordable diagnostics and therapeutics.

show abstract

“…By raising the profile of lung science, education and advocacy, we can improve the care for chronic respiratory diseases in Europe and worldwide. 24 1. Encouraging healthcare provider and patient engagement in a multidisciplinary approach and ensuring that lung health is accessible for all is a major goal to be reached in the near future 2.…”

Section: European Respiratory Societymentioning

confidence: 99%